Wall Street Analysts Predict a 244.05% Upside in Spyre Therapeutics (SYRE): Here's What You Should Know

Spyre Therapeutics (SYRE) closed the last trading session at $15.55, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 53.50 indicates a 244.1% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $16.36. While the lowest estimate of$ 21 indicates a 35.1% increase from the current price level, the most optimistic analyst ...